Inhibikase Therapeutics, Inc.
IKT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001750149
No open-market purchases or sales by Inhibikase Therapeutics, Inc. insiders were filed in the last 90 days; 105 institutions reported holding it in 13F filings for Q2 2026, worth $239.2M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Inhibikase Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 48
- +1 vs. Q1 2025
- Shares held
- 54.5M
- +3.05M (+5.9%) vs. Q1 2025
- Total value
- $106.3M
- −$6.40M (−5.7%) vs. Q1 2025
- New holders
- 24
- 11 more added
- Sold out
- 23
- 6 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IKT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 105 | $239.2M |
| Q1 2026 | 104 | $193.4M |
| Q4 2025 | 74 | $218.2M |
| Q3 2025 | 54 | $89.0M |
| Q2 2025 | 48 | $106.3M |
| Q1 2025 | 47 | $112.7M |
| Q4 2024 | 31 | $162.7M |
| Q3 2024 | 11 | $1.12M |
| Q2 2024 | 12 | $1.02M |
| Q1 2024 | 12 | $443.8K |
| Q4 2023 | 11 | $298.9K |
| Q3 2023 | 13 | $597.6K |
| Q2 2023 | 14 | $2.69M |
| Q1 2023 | 17 | $2.91M |
| Q4 2022 | 19 | $719.4K |
| Q3 2022 | 24 | $2.78M |
| Q2 2022 | 22 | $2.49M |
| Q1 2022 | 24 | $6.33M |
| Q4 2021 | 26 | $6.85M |
| Q3 2021 | 21 | $7.78M |
| Q2 2021 | 14 | $10.6M |
| Q1 2021 | 9 | $975.0K |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Inhibikase Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tower Research Capital LLC (TRC) | 100 | $195 | 0.00% | +100 | New |
| Raymond James Financial Inc | 1,000 | $1.95K | 0.00% | +1,000 | New |
| Sterling Capital Management LLC | 1,505 | $2.94K | 0.00% | +1,505 | New |
| Amalgamated Bank | 2,065 | $4.00K | 0.00% | +2,065 | New |
| California State Teachers Retirement System | 3,773 | $7.36K | 0.00% | +3,773 | New |
| Royal Bank of Canada | 4,587 | $10.0K | 0.00% | +4,587 | New |
| Legal & General Group Plc | 5,504 | $10.7K | 0.00% | +5,504 | New |
| Ameritas Investment Partners, Inc. | 6,174 | $12.0K | 0.00% | +6,174 | New |
| BNP Paribas Arbitrage, SA | 9,182 | $17.9K | 0.00% | +9,182 | New |
| Buckingham Strategic Partners | 10,708 | $20.9K | 0.00% | +10,708 | New |
| ProShare Advisors LLC | 12,401 | $24.2K | 0.00% | +12,401 | New |
| Caxton Corp | 16,393 | $32.0K | 0.32% | 00.0% | Unchanged |
| Police & Firemen's Retirement System of New Jersey | 17,638 | $34.4K | 0.00% | +17,638 | New |
| Voya Investment Management LLC | 18,755 | $36.6K | 0.00% | +18,755 | New |
| Bank of America Corp | 19,216 | $37.5K | 0.00% | −25,810−57.3% | Reduced |
| Citigroup Inc | 20,393 | $39.8K | 0.00% | −5,372−20.8% | Reduced |
| JPMorgan Chase & Co | 28,579 | $55.7K | 0.00% | +28,579 | New |
| Invesco Ltd. | 30,712 | $59.9K | 0.00% | +30,712 | New |
| Price T Rowe Associates Inc | 30,606 | $60.0K | 0.00% | +30,606 | New |
| LMR Partners LLP | 31,092 | $60.6K | 0.00% | 00.0% | Unchanged |
| Intech Investment Management LLC | 31,406 | $61.2K | 0.00% | +31,406 | New |
| Mirae Asset Global ETFs Holdings Ltd. | 33,023 | $64.4K | 0.00% | +33,023 | New |
| Wells Fargo & Company | 38,326 | $74.7K | 0.00% | +38,159+22,849.7% | Added |
| UBS Group AG | 38,674 | $75.4K | 0.00% | −6,592−14.6% | Reduced |
| Rhumbline Advisers | 58,524 | $114.1K | 0.00% | +58,524 | New |
| New York State Common Retirement Fund | 60,700 | $118.4K | 0.00% | +60,700 | New |
| Nuveen, LLC | 78,659 | $153.4K | 0.00% | +78,659 | New |
| Morgan Stanley | 99,678 | $194.4K | 0.00% | +78,032+360.5% | Added |
| Barclays PLC | 110,252 | $215.0K | 0.00% | +26,252+31.3% | Added |
| Bank of New York Mellon Corp | 132,473 | $258.3K | 0.00% | +132,473 | New |
| FMR LLC | 144,239 | $281.3K | 0.00% | +144,239 | New |
| Charles Schwab Investment Management Inc | 152,298 | $297.0K | 0.00% | +152,298 | New |
| Blair William & Co | 156,953 | $306.1K | 0.00% | +1,000+0.6% | Added |
| Susquehanna International Group, LLP | 383,071 | $747.0K | 0.00% | −121,554−24.1% | Reduced |
| Northern Trust Corp | 392,716 | $765.8K | 0.00% | +328,705+513.5% | Added |
| State Street Corp | 397,812 | $775.7K | 0.00% | +355,928+849.8% | Added |
| Stonepine Capital Management, LLC | 733,793 | $1.43M | 1.41% | −181,180−19.8% | Reduced |
| Geode Capital Management, LLC | 1,066,700 | $2.08M | 0.00% | +741,940+228.5% | Added |
| Nantahala Capital Management, LLC | 2,190,000 | $4.27M | 0.30% | 00.0% | Unchanged |
| Blackstone Group Inc. | 2,638,276 | $5.14M | 0.02% | +567,592+27.4% | Added |
| BlackRock, Inc. | 2,728,168 | $5.32M | 0.00% | +2,304,189+543.5% | Added |
| Vanguard Group Inc | 3,224,370 | $6.29M | 0.00% | +375,707+13.2% | Added |
| ADAR1 Capital Management, LLC | 5,122,105 | $9.99M | 1.62% | 00.0% | Unchanged |
| Commodore Capital LP | 5,397,488 | $10.5M | 0.74% | +53,056+1.0% | Added |
| Perceptive Advisors LLC | 5,432,293 | $10.6M | 0.40% | −492,707−8.3% | Reduced |
| Fairmount Funds Management LLC | 6,125,000 | $11.9M | 1.55% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 6,325,000 | $12.3M | 0.85% | 00.0% | Unchanged |
| Sands Capital Ventures, LLC | 10,950,000 | $21.4M | 4.20% | 00.0% | Unchanged |
| Millennium Management LLC | 0 | $0 | 0.00% | −913,502−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −166,025−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −155,270−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −116,249−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −81,161−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −65,906−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −56,000−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −54,845−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −35,625−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −32,538−100.0% | Sold out |
| Diametric Capital, LP | 0 | $0 | 0.00% | −28,366−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −26,775−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −16,876−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −14,976−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −14,800−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −13,712−100.0% | Sold out |
| Stifel Financial Corp | 0 | $0 | 0.00% | −13,129−100.0% | Sold out |
| Quantessence Capital LLC | 0 | $0 | 0.00% | −13,005−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −11,098−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −11,067−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −10,384−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −9,043−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −1,980−100.0% | Sold out |